How mRNA technology is improving the flu Shot: The Big Take podcast by Bloomberg
It’s estimated that half a million or more people around the world die of influenza each year. And many of these deaths could be prevented with a highly effective, widely used flu shot.
|
ESWI Airborne: Meet the Members
Celebrating ESWI 30 years!
Who would have taken virus isolation for granted 30 years ago? How and why did ESWI transform from a pure virology-based network to one encompassing a public health perspective?
|
ESWI Airborne: Meet the Members
Virus infections, blood clots and bleeding
What do Ebola, Dengue Fever, Lassa Fever, or other hemorrhagic fevers, that often inspire Hollywood productions, have in common with respiratory viruses, such as influenza or Sars-Cov2?
|
ESWI Airborne: Meet the Members
Universal flu vaccines – soon a reality?
How close are we to a universal flu vaccine? Are universal corona vaccines attainable? What are some of the main challenges facing scientists in their quest to develop these vaccines?
Shaping the Future of Global Next-Generation Influenza Vaccine Research
Flu Vaccine Forum. A series of conversations with global public health experts about transforming the vaccine ecosystem towards a flu-free future.
|
ESWI Airborne: Meet the Members
How does a virus cause disease after transmission?
In this fascinating episode pathomechanism is explained and we learn how recent research has shown that acute virus infections may cause long-term health impairments. Even mild flu during pregnancy can affect susceptibility to disease in offspring.
|
ESWI Airborne: Meet the Members
Respiratory tract infections in children - our paediatrician's insight and bold vision for the future
Her passion, love and interest to care for children is evident in this personal account by Paula Tähtinen, Clinical Lecturer, Paediatrics and Adolescent Medicine / Adjunct Professor, University of Turku, Finland and ESWI Board Member.
|
ESWI Airborne: Meet the Members
A geriatrician's insight into reducing the burden of disease in older adults
Who is at an increased risk of adverse effects from an RSV infection? What is the burden of disease and what should be done to alleviate the risk and increase awareness?
|
ESWI Airborne: Meet the Members
Spotlight on the burden of flu for people living with diabetes
Why are people with diabetes more at risk from flu? What are the options for reducing the risk? What are the challenges and solutions to increase awareness across health care professionals, researchers and patients themselves?
|
ESWI Airborne: Meet the Members
Walk the talk on immunisation
With a wealth of experience, Professor of Epidemiology and former Minister of Health, ESWI Board Member Roman Prymula gives a personal testimony of the COVID-19 pandemic and the different perspectives of politics vs science when it comes to health policy.
|
ESWI Airborne: Meet the Members
Using mathematical modelling to predict virus evolution and inform pandemic response
The dynamic interplay between epidemiological research, virus evolution, and mathematical modelling is skilfully described by Dr Colin Russell, Professor of Applied Evolutionary Biology and ESWI Board Member.